{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:32:22Z","timestamp":1784673142320,"version":"3.55.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neuropharm.2020.108072","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T11:00:33Z","timestamp":1585652433000},"page":"108072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Differential effects of traxoprodil and S-ketamine on quantitative EEG and auditory event-related potentials as translational biomarkers in preclinical trials in rats and mice"],"prefix":"10.1016","volume":"171","author":[{"given":"Henrike","family":"Raith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Schuelert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venceslas","family":"Duveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Roucard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Plano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Dorner-Ciossek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Ferger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108072_bib1","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1038\/tp.2017.198","article-title":"Ketamine: differential neurophysiological dynamics in functional networks in the rat brain","volume":"7","author":"Ahnaou","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108072_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2017.07.009","article-title":"Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia","volume":"191","author":"Avissar","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2020.108072_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-7020-5307-8.00002-8","article-title":"Brain's alpha, beta, gamma, delta, and theta oscillations in neuropsychiatric diseases","volume":"62","author":"Ba\u015far","year":"2013","journal-title":"Suppl. Clin. neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fninf.2017.00067","article-title":"The patient repository for EEG data + computational tools (PRED+CT)","volume":"11","author":"Cavanagh","year":"2017","journal-title":"Front. Neuroinf."},{"key":"10.1016\/j.neuropharm.2020.108072_bib6","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1523\/JNEUROSCI.19-16-06844.1999","article-title":"Subtype-dependence of NMDA receptor channel open probability","volume":"19","author":"Chen","year":"1999","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00348","article-title":"Effects of ketamine on resting-state EEG activity and their relationship to perceptual\/dissociative symptoms in healthy humans","volume":"7","author":"de la Salle","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000443175","article-title":"Pharmaco-EEG studies in animals: a history-based introduction to contemporary translational applications","volume":"72","author":"Drinkenburg","year":"2015","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000442210","article-title":"Pharmaco-EEG studies in animals: an overview of contemporary translational applications","volume":"72","author":"Drinkenburg","year":"2015","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1162\/jocn.2008.20097","article-title":"Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice","volume":"20","author":"Ehrlichman","year":"2008","journal-title":"J. Cognit. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1124\/mol.107.037333","article-title":"Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors","volume":"72","author":"Erreger","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1476-5381.1973.tb08243.x","article-title":"Role of 5-hydroxytryptamine in ketamine-induced hypothermia in the rat","volume":"48","author":"Fahim","year":"1973","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nbd.2012.05.003","article-title":"Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice","volume":"47","author":"Featherstone","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.108072_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2017.07.039","article-title":"Mismatch negativity in preclinical models of schizophrenia","volume":"191","author":"Featherstone","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2020.108072_bib15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuropharm.2009.11.014","article-title":"Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge","volume":"58","author":"Fell","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/npp.2013.290","article-title":"Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat","volume":"39","author":"Gass","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125509","article-title":"Sleep\/wake dynamics changes during maturation in rats","volume":"10","author":"Gradwohl","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108072_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1550059416645980","article-title":"Mismatch negativity in first-episode schizophrenia: a meta-analysis","volume":"48","author":"Haigh","year":"2017","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2013.00083","article-title":"The functional significance of delta oscillations in cognitive processing","volume":"7","author":"Harmony","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2017.03.042","article-title":"Late deviance detection in rats is reduced, while early deviance detection is augmented by the NMDA receptor antagonist MK-801","volume":"191","author":"Harms","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2020.108072_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biopsycho.2015.07.006","article-title":"Criteria for determining whether mismatch responses exist in animal models: focus on rodents","volume":"116","author":"Harms","year":"2016","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuropharm.2014.05.037","article-title":"Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms","volume":"85","author":"Hiyoshi","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0091-3057(91)90571-I","article-title":"Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice","volume":"40","author":"Irifune","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108072_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2017.06.023","article-title":"Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia","volume":"191","author":"Javitt","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2020.108072_bib25","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1073\/pnas.93.21.11962","article-title":"Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia","volume":"93","author":"Javitt","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108072_bib26","series-title":"Guidelines for the Recording and Evaluation of Pharmaco-EEG Data in Man: the International Pharmaco-EEG Society (IPEG)","first-page":"201","volume":"66","author":"Jobert","year":"2012"},{"key":"10.1016\/j.neuropharm.2020.108072_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12725","article-title":"Translational psychiatry\u2014light at the end of the tunnel","volume":"1344","author":"Jones","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1254\/jphs.FP0070272","article-title":"Lipopolysaccharide- and glutamate-induced hypothalamic hydroxyl radical elevation and fever can be suppressed by N-Methyl-D-aspartate-Receptor antagonists","volume":"104","author":"Kao","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152729","article-title":"The qEEG signature of selective NMDA NR2B negative allosteric modulators; A potential translational biomarker for drug development","volume":"11","author":"Keavy","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108072_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00429-011-0351-8","article-title":"Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia","volume":"217","author":"Kittelberger","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2020.108072_bib31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.biopsych.2011.10.002","article-title":"Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations","volume":"71","author":"Kocsis","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.5665\/sleep.1972","article-title":"State-dependent increase of cortical gamma activity during REM sleep after selective blockade of NR2B subunit containing NMDA receptors","volume":"35","author":"Kocsis","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2020.108072_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/cns.12081","article-title":"Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits","volume":"19","author":"Kocsis","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2020.108072_bib34","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.neuroscience.2008.04.045","article-title":"The magnitude of hippocampal long term depression depends on the synaptic location of activated NR2-containing N-methyl-D-aspartate receptors","volume":"154","author":"Kollen","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108072_bib35","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1111\/j.1460-9568.2012.08263.x","article-title":"Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing","volume":"36","author":"Kulikova","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib36","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1523\/JNEUROSCI.16-11-03549.1996","article-title":"Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels","volume":"16","author":"Kuner","year":"1996","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib37","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1162\/jocn.2009.21305","article-title":"Ketamine modulates theta and gamma oscillations","volume":"22","author":"Lazarewicz","year":"2010","journal-title":"J. Cognit. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/npp.2017.176","article-title":"Rodent mismatch negativity\/theta neuro-oscillatory response as a translational neurophysiological biomarker for N-Methyl-D-Aspartate receptor-based new treatment development in schizophrenia","volume":"43","author":"Lee","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bcp.2010.10.002","article-title":"Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research","volume":"81","author":"Leiser","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 Years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/nyas.12730","article-title":"Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia","volume":"1344","author":"Light","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","article-title":"Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268","volume":"117","author":"Lorrain","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108072_bib43","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nn.3459","article-title":"Developmental origin dictates interneuron AMPA and NMDA receptor subunit composition and plasticity","volume":"16","author":"Matta","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.neuro.20.1.185","article-title":"Sleep and arousal: thalamocortical mechanisms","volume":"20","author":"McCormick","year":"1997","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1527-3458.1998.tb00073.x","article-title":"CP-101,606: an NR2B-selective NMDA receptor antagonist","volume":"4","author":"Menniti","year":"1998","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2020.108072_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biopsycho.2016.01.011","article-title":"The neurobiology of MMN and implications for schizophrenia","volume":"116","author":"Michie","year":"2016","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2020.108072_bib48","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.256.5060.1217","article-title":"Heteromeric NMDA receptors: molecular and functional distinction of subtypes","volume":"256","author":"Monyer","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108072_bib49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/0028-3908(95)00109-J","article-title":"Structure and function of the NMDA receptor channel","volume":"34","author":"Mori","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bspc.2015.07.003","article-title":"Review on EEG and ERP predictive biomarkers for major depressive disorder","volume":"22","author":"Mumtaz","year":"2015","journal-title":"Biomed. Signal Process Contr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib51","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/npp.2015.298","article-title":"Differential effects of an NR2B NAM and ketamine on synaptic potentiation and gamma synchrony: relevance to rapid-onset antidepressant efficacy","volume":"41","author":"Nagy","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib52","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/mds.22169","article-title":"Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism","volume":"23","author":"Nutt","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2020.108072_bib53","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.neuropharm.2011.04.006","article-title":"Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia","volume":"62","author":"Phillips","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib54","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2007.10.006","article-title":"N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex","volume":"63","author":"Pinault","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11011-016-9810-5","article-title":"Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice","volume":"31","author":"Poleszak","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2020.108072_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib57","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.clinph.2015.10.062","article-title":"The effects of ketamine on the mismatch negativity (MMN) in humans - a meta-analysis","volume":"127","author":"Rosburg","year":"2016","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2011.12.049","article-title":"NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia","volume":"46","author":"Saunders","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.108072_bib59","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0006-3495(96)79782-5","article-title":"Simultaneous measurement of Ca2+ influx and reversal potentials in recombinant N-methyl-D-aspartate receptor channels","volume":"70","author":"Schneggenburger","year":"1996","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2020.108072_bib60","article-title":"A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology","volume":"6","author":"Schuelert","year":"2018","journal-title":"Phys. Rep."},{"key":"10.1016\/j.neuropharm.2020.108072_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/eb-2016-102355","article-title":"Ketamine for treatment-resistant depression: recent developments and clinical applications","volume":"19","author":"Schwartz","year":"2016","journal-title":"Evid. Base Ment. Health"},{"key":"10.1016\/j.neuropharm.2020.108072_bib62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuropharm.2014.07.008","article-title":"Enhancing ketamine translational pharmacology via receptor occupancy normalization","volume":"86","author":"Shaffer","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib63","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1017\/S1461145714000649","article-title":"Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex","volume":"17","author":"Shirakawa","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fpsyt.2014.00096","article-title":"NR2B antagonist CP-101,606 abolishes pitch-mediated deviance detection in awake rats","volume":"5","author":"Sivarao","year":"2014","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib65","series-title":"Traxoprodil Augments the Antidepressant-like Activity of Agomelatine but Not of Mianserin or Tianeptine in the Forced Swim Test in Mice","first-page":"960","volume":"68","author":"Stasiuk","year":"2016"},{"key":"10.1016\/j.neuropharm.2020.108072_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00702-016-1657-8","article-title":"Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice","volume":"124","author":"Stasiuk","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2020.108072_bib67","first-page":"18","article-title":"European Quality in Preclinical Data (EQIPD): een breed consortium voor het verbeteren van de kwaliteit van proefdieronderzoek","volume":"57","author":"Steckler","year":"2018","journal-title":"Biotechniek"},{"key":"10.1016\/j.neuropharm.2020.108072_bib68","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpsychires.2009.08.013","article-title":"Wake and sleep EEG provide biomarkers in depression","volume":"44","author":"Steiger","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.108072_bib69","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jneumeth.2009.08.014","article-title":"Automated analysis of sleep\u2013wake state in rats","volume":"184","author":"Stephenson","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2020.108072_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cophys.2017.12.004","article-title":"Triheteromeric NMDA receptors: from structure to synaptic physiology","volume":"2","author":"Stroebel","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib71","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200645100-00003","article-title":"Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers","volume":"45","author":"Taylor","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2020.108072_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2008.02.006","article-title":"Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats","volume":"1203","author":"Tikhonravov","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108072_bib73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fpsyt.2013.00171","article-title":"Mismatch negativity: translating the potential","volume":"4","author":"Todd","year":"2013","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0924270800031768","article-title":"Mismatch negativity in schizophrenia: effect of probability, deviant type and duration of illness","volume":"18","author":"Todd","year":"2006","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biopsych.2007.02.016","article-title":"Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia","volume":"63","author":"Todd","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib76","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.neuron.2008.09.039","article-title":"Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks","volume":"60","author":"von Engelhardt","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108072_bib77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.physbeh.2014.01.006","article-title":"Synergistic interaction between ketamine and magnesium in lowering body temperature in rats","volume":"127","author":"Vu\u010dkovi\u0107","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108072_bib78","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.physbeh.2007.02.010","article-title":"Effects of age and sex on ketamine-induced hyperactivity in rats","volume":"91","author":"Wilson","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108072_bib79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2013.01.016","article-title":"Influence of GluN2 subunit identity on NMDA receptor function","volume":"74","author":"Wyllie","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108072_bib80","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nn.3058","article-title":"NMDA receptor permeation: a light in the tunnel","volume":"15","author":"Wyllie","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108072_bib81","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/B978-0-7020-5307-8.00016-8","article-title":"Brain oscillations as biomarkers in neuropsychiatric disorders","volume":"62","author":"Yener","year":"2013","journal-title":"Suppl. Clin. neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108072_bib82","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10673229.2010.511059","article-title":"Glutamatergic modulators: the future of treating mood disorders?","volume":"18","author":"Zarate","year":"2010","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108072_bib83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:01:23Z","timestamp":1758438083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820301386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":83,"alternative-id":["S0028390820301386"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108072","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of traxoprodil and S-ketamine on quantitative EEG and auditory event-related potentials as translational biomarkers in preclinical trials in rats and mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108072"}}